首页> 外文期刊>International Journal of Basic & Clinical Pharmacology >Comparative studies on the efficacy of lincomycin and bacitracin for the control of necrotic enteritis in broiler chickens
【24h】

Comparative studies on the efficacy of lincomycin and bacitracin for the control of necrotic enteritis in broiler chickens

机译:林可霉素和杆菌肽控制肉鸡坏死性肠炎疗效的比较研究

获取原文
           

摘要

Background: The present study was conducted to evaluate the efficacy of lincomycin and/or bacitracin for control of experimentally-induced Clostridium perfringens (CP) infection in broiler chickens. Methods: A total of 100 one-day-old Cobb-mixed chicks were divided into five groups (A, B, C, D and E, each of 20 bird). At the 15th day of age, all birds (except group A) were inoculated orally with CP broth culture (109 CFU/mL). Two days later, drugs were orally administered once daily for five consecutive days as follow; Group A and B were left untreated. Group C, D, and E were treated with lincomycin (0.5 g/l), bacitracin (100 mg/l), lincomycin and bacitracin, respectively. The efficacy of used drugs was estimated based on clinical symptoms, body weight, weight gain, feed conversion rate. Hematobiochemical changes were also determined. Results: Necrotic enteritis in broiler chickens induced a significant decrease in body weight, weight gain, erythrocytic count, hemoglobin content, PCV %, serum proteins, catalase, and superoxide dismutase. Additionally, a marked decrease in serum lipids was obtained. Furthermore, a significant increase in feed conversion rate, leukocytic count, phagocytic activity, phagocytic index, serum total globulin, γ globulin and malondialdehyde coupled with a marked increase in β and α globulins were determined. Medication of infected broilers with lincomycin and/or bacitracin improved clinical signs and reduced mortality rate to 8, 6 and 2%, respectively, as well as restored the performance and hematobiochemical alterations. Conclusions: a combination of lincomycin and bacitracin was of considerable value for the control of necrotic enteritis in broiler chickens.
机译:背景:本研究旨在评估林可霉素和/或杆菌肽对控制实验诱导的肉鸡产气荚膜梭状芽胞杆菌(CP)感染的功效。方法:将100只1日龄Cobb混合雏鸡分为5组(A,B,C,D和E,每组20只)。在第15日龄时,所有鸡只(A组除外)都口服CP肉汤培养物(109 CFU / mL)。两天后,如下连续五天每天口服一次药物; A组和B组未经治疗。 C,D和E组分别用林可霉素(0.5 g / l),杆菌肽(100 mg / l),林可霉素和杆菌肽治疗。根据临床症状,体重,体重增加,饲料转化率评估用过的药物的疗效。还确定了血液生化变化。结果:肉鸡坏死性肠炎导致体重,体重增加,红细胞计数,血红蛋白含量,PCV%,血清蛋白,过氧化氢酶和超氧化物歧化酶显着下降。另外,获得了血清脂质的显着降低。此外,确定了饲料转化率,白细胞计数,吞噬活性,吞噬指数,血清总球蛋白,γ球蛋白和丙二醛的显着增加,以及β和α球蛋白的显着增加。用林可霉素和/或杆菌肽对感染的肉鸡进行药物治疗可改善临床症状,并将死亡率分别降低至8%,6%和2%,并且恢复了性能和血液生化改变。结论:林可霉素和杆菌肽的联合使用对控制肉鸡坏死性肠炎具有重要价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号